A Study of Quintuple Therapy to Treat COVID-19 Infection
-
- STATUS
- Recruiting
-
- End date
- Sep 8, 2024
-
- participants needed
- 600
-
- sponsor
- ProgenaBiome
Summary
This is a Phase II interventional study will test the efficacy of quintuple therapy (Hydroxychloroquine, Azithromycin, Vitamin C, Vitamin D, and Zinc) in the treatment of patients with COVID-19 infection).
Description
In this study patients will be treated with a combination therapy to determine if this combination can effectively treat COVID-19. Treatment will last ten days. The study will last 24 weeks.
Details
| Condition | Coronavirus 19, Corona Virus Infection, *COVID-19, Coronavirus Infection, Coronavirus, Sars-CoV2, Covid-19, SARS COV2 |
|---|---|
| Treatment | Azithromycin, Vitamin C, zinc, hydroxychloroquine, Vitamin D |
| Clinical Study Identifier | NCT04334512 |
| Sponsor | ProgenaBiome |
| Last Modified on | 12 September 2021 |
Eligibility
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer